AB0446 Progressive Spacing TOCILIZUMAB Infusions after Remission in Rheumatoid Arthritis: the Absence of Erosion Would BE Determinant in Choosing This Strategy

Background Rheumatoid arthritis (RA) is the most common inflammatory rheumatic disease. Tocilizumab (TCZ) is the first therapeutic agent targeting IL-6 to be effective in RA. Recent ACR/EULAR recommendations highlighted the aim to treat RA patients quickly in order to obtain a clinical remission. Ho...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annals of the rheumatic diseases 2014-06, Vol.73 (Suppl 2), p.955-956
Hauptverfasser:	Le Blay, P., Rubenstein, E., Ferreira Lopez, R., Jorgensen, C., Pers, Y.M.
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!